The enigmatic role of cyclin D1 in multiple myeloma
- 1 February 2005
- journal article
- review article
- Published by Wiley in International Journal of Cancer
- Vol. 115 (2) , 171-176
- https://doi.org/10.1002/ijc.20907
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Advances in biology of multiple myeloma: clinical applicationsBlood, 2004
- The activities of cyclin D1 that drive tumorigenesisTrends in Molecular Medicine, 2004
- Relevance of cyclin D1 level in the pathogenesis of multiple myelomaBlood, 2003
- Clinical and biologic implications of recurrent genomic aberrations in myelomaBlood, 2003
- Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapyBlood, 2002
- Alterations of the cyclin D1/pRb/p16INK4A pathway in multiple myelomaLeukemia, 2002
- Multiple myeloma: evolving genetic events and host interactionsNature Reviews Cancer, 2002
- Ectopic expression of cyclin D1 impairs the proliferation and enhances the apoptosis of a murine lymphoid cell lineCell Death & Differentiation, 2001
- Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3Nature Genetics, 1997
- Cyclin D1 as a cellular proto-oncogeneSeminars in Cancer Biology, 1995